Palatin Technologies competitorsClear all

Palatin Technologies's top competitors include Albumedix and Acticor Biotech.
Palatin Technologies
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
Albumedix
Albumedix
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
Acticor Biotech
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
Founding Date
Founding Date
1986
Founding Date
2016
Founding Date
2013
Type
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
East Windsor, US HQ
Locations
Nottinghamshire, GB HQ
Nottingham, GB
Locations
Paris, FR HQ
Paris, FR
Employees
Employees
185% decrease
Employees
67
Employees
2011% increase
Twitter followers
Twitter followers
533
Twitter followers
138
Twitter followers
331
Alexa Website Rank
Alexa Website Rank
307211
Alexa Website Rank
381673
Alexa Website Rank
257693

Financial

Revenue (est.)
Revenue (est.)
$60.3m (FY, 2019)
Revenue (est.)
£26.1m (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
$35.8m (FY, 2019)
Net income
£5m (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 104.2m
Total funding raised
N/A
Total funding raised
$ 33.3m
For sources of this data, please see the company profile

View company profiles

Albumedix
HQ
Nottinghamshire, GB
Employees
67

Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.

View company
Acticor Biotech
HQ
Paris, FR
Employees
20↑ 11% increase

Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.

View company